🇺🇸 FDA
Pipeline program

A single and multiple ascending dose study of topical ladarixin ophthalmic solution in healthy volunteers

LDX-HV-101

Phase 1 other active

Quick answer

A single and multiple ascending dose study of topical ladarixin ophthalmic solution in healthy volunteers for Ocular inflammatory conditions is a Phase 1 program (other) at Dompe' Farmaceutici S.p.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Dompe' Farmaceutici S.p.A.
Indication
Ocular inflammatory conditions
Phase
Phase 1
Modality
other
Status
active

Clinical trials